What dermoscopy tells us about nevogenesis

Journal of Dermatology

Volumn 38, Issue 1, 2011, Pages 16-24

  Zalaudek, Iris ^a   Catricalã, Caterina ^b   Moscarella, Elvira ^b   Argenziano, Giuseppe ^c  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

dermoscopy; genetic; nevi; nevogenesis

Indexed keywords

B RAF KINASE;

APOPTOSIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONFOCAL MICROSCOPY; DIAGNOSTIC ACCURACY; EPILUMINESCENCE MICROSCOPY; GOLD STANDARD; HISTOPATHOLOGY; HUMAN; IN VIVO STUDY; MELANOCYTE; MELANOCYTIC NEVUS; OUTCOME ASSESSMENT;

ADOLESCENT; ADULT; CELL TRANSFORMATION, NEOPLASTIC; CHILD; DERMOSCOPY; HUMANS; MELANOMA; MUTATION; NEVUS; PROTO-ONCOGENE PROTEINS B-RAF; SKIN NEOPLASMS; YOUNG ADULT;

EID: 78650685913     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2010.01141.x     Document Type: Article

References (35)

1. Argenziano G, Zalaudek I, Ferrara G, et al. Proposal of a new classification system for melanocytic naevi. Br J Dermatol 2007; 157: 217-227.
2. Kincannon J, Boutzale C,. The Physiology of Pigmented Nevi. Pediatrics 1999; 104: 1042-1045.
3. Scope A, Marghoob AA, Dusza SW, et al. Dermoscopic patterns of naevi in fifth grade children of the Framingham school system. Br J Dermatol 2008; 158: 1041-1049.
4. Zalaudek I, Grinschgl S, Argenziano G, et al. Age-related prevalence of dermoscopy patterns in acquired melanocytic naevi. Br J Dermatol 2006; 154: 299-304.
5. Kittler H, Seltenheim M, Dawid M, et al. Frequency and characteristics of enlarging common melanocytic nevi. Arch Dermatol 2000; 136: 316-320.
6. Terushkin V, Scope A, Halpern AC, Marghoob AA,. Pathways to involution of nevi: insights from dermoscopic follow-up. Arch Dermatol 2010; 146: 459-460.
7. Witt C, Krengel S,. Clinical and epidemiological aspects of subtypes of melanocytic nevi (Flat nevi, Miescher nevi, Unna nevi). Dermatol Online J 2010; 16: 1.
8. Seidenari S, Pellacani G, Martella A, et al. Instrument-, age- and site-dependent variations of dermoscopic patterns of congenital melanocytic naevi: a multicentre study. Br J Dermatol 2006; 155: 56-61.
9. Changchien L, Dusza SW, Agero AL, et al. Age- and site-specific variation in the dermoscopic patterns of congenital melanocytic nevi: an aid to accurate classification and assessment of melanocytic nevi. Arch Dermatol 2007; 143: 1007-1014.
10. Zalaudek I, Argenziano G, Mordente I, et al. Nevus type in dermoscopy is related to skin type in white persons. Arch Dermatol 2007; 143: 351-356.
11. Zalaudek I, Hofmann-Wellenhof R, Kittler H, et al. A dual concept of nevogenesis: theoretical considerations based on dermoscopic features of melanocytic nevi. J Dtsch Dermatol Ges 2007; 5: 985-992.
12. Zalaudek I, Leinweber B, Hofmann-Wellenhof R, et al. The epidermal and dermal origin of melanocytic tumors: theoretical considerations based on epidemiologic, clinical, and histopathologic findings. Am J Dermatopathol 2008; 30: 403-406.
13. Cramer SF,. Speckled lentiginous nevus (nevus spilus): the "roots" of the "melanocytic garden". Arch Dermatol 2001; 137: 1654-1655.
14. Gleason BC, Crum CP, Murphy GF,. Expression patterns of MITF during human cutaneous embryogenesis: evidence for bulge epithelial expression and persistence of dermal melanoblasts. J Cutan Pathol 2008; 35: 615-622.
15. Alexeev V, Yoon K,. Distinctive role of the cKit receptor tyrosine kinase signaling in mammalian melanocytes. J Invest Dermatol 2006; 126: 1102-1110.
16. Horikawa T, Norris DA, Yohn JJ, et al. Melanocyte mitogens induce both melanocyte chemokinesis and chemotaxis. J Invest Dermatol 1995; 104: 256-259.
17. Blokx WA, van Dijk MC, Ruiter DJ,. Molecular cytogenetics of cutaneous melanocytic lesions-diagnostic, prognostic and therapeutic aspects. Histopathology 2010; 56: 121-132.
18. Thomas NE,. BRAF somatic mutations in malignant melanoma and melanocytic naevi. Melanoma Res 2006; 16: 97-103.
19. Gray-Schopfer VC, Cheong SC, Chong H, et al. Cellular senescence in naevi and immortalisation in melanoma: a role for p16? Br J Cancer 2006; 95: 496-505.
20. Michaloglou C, Vredeveld LC, Soengas MS, et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 2005; 436: 720-724.
21. Houben R, Ortmann S, Drasche A, et al. Proliferation arrest in B-Raf mutant melanoma cell lines upon MAPK pathway activation. J Invest Dermatol 2009; 129: 406-414.
22. Hafner C, Stoehr R, van Oers JM, et al. The absence of BRAF, FGFR3, and PIK3CA mutations differentiates lentigo simplex from melanocytic nevus and solar lentigo. J Invest Dermatol 2009; 129: 2730-2735.
23. Ichii-Nakato N, Takata M, Takayanagi S, et al. High frequency of BRAFV600E mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi. J Invest Dermatol 2006; 126: 2111-2118.
24. Kumar R, Angelini S, Snellman E, Hemminki K,. BRAF mutations are common somatic events in melanocytic nevi. J Invest Dermatol 2004; 122: 342-348.
25. Wu J, Rosenbaum E, Begum S, Westra WH,. Distribution of BRAF T1799A (V600E) mutations across various types of benign nevi: implications for melanocytic tumorigenesis. Am J Dermatopathol 2007; 29: 534-537.
26. Takata M, Murata H, Saida T,. Molecular pathogenesis of malignant melanoma: a different perspective from the studies of melanocytic nevus and acral melanoma. Pigment Cell Melanoma Res 2010; 23: 64-71.
27. Pellacani G, Scope A, Ferrari B, et al. New insights into nevogenesis: in vivo characterization and follow-up of melanocytic nevi by reflectance confocal microscopy. J Am Acad Dermatol 2009; 61: 1001-1013.
28. Zalaudek I, Docimo G, Argenziano G,. Using dermoscopic criteria and patientrelated factors for the management of pigmented melanocytic nevi. Arch Dermatol 2009; 145: 816-826.
29. Alaibac M, Piaserico S, Rossi CR, et al. Eruptive melanocytic nevi in patients with renal allografts: report of 10 cases with dermoscopic findings. J Am Acad Dermatol 2003; 49: 1020-1022.
30. Belloni Fortina A, Piaserico S, Zattra E, Alaibac M,. Dermoscopic features of eruptive melanocytic naevi in an adult patient receiving immunosuppressive therapy for Crohn's disease. Melanoma Res 2005; 15: 223-224.
31. Cardones AR, Grichnik JM,. Alpha-Melanocyte-stimulating hormone-induced eruptive nevi. Arch Dermatol 2009; 145: 441-444.
32. Lin J, Takata M, Murata H, et al. Polyclonality of BRAF mutations in acquired melanocytic nevi. J Natl Cancer Inst 2009; 101: 1423-1427.
33. Loewe R, Kittler H, Fischer G, et al. BRAF kinase gene V599E mutation in growing melanocytic lesions. J Invest Dermatol 2004; 123: 733-736.
34. Viros A, Fridlyand J, Bauer J, et al. Improving melanoma classification by integrating genetic and morphologic features. PLoS Med 2008; 5: e120.
35. Zalaudek I, Guelly C, Pellacani G, et al. The dermoscopical and histopathological patterns of nevi correlate with the frequency of BRAF mutations. J Invest Dermatol 2010; [Epub ahead of print] doi: 10.1038/jid.2010.332.